A listing of craig-lammert-md medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.
The primary objectives of this study are to evaluate the safety of single IV doses of UX701with Wilson disease, to select the UX701 dose with the best benefit/risk profile based on the totality of safety and efficacy data and to evaluate the effect of UX701 ongulation.
This is a Phase 2a, multi-center, placebo-controlled study in which patients with autoimmune hepatitis will receive zetomipzomib or placebo in addition to standard-of-care for 24 weeks.